ArticleAJPM focus2025
Young Adult Cannabis, Alcohol, Nicotine, and Nonprescribed Pain Reliever Use in Washington State Before and During COVID-19 Pandemic.
Article in AJPM focus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pandemic-Related Stressors Linked to Cannabis and Nicotine Use in a Longitudinal Study of Asian, Latinx, and White Young Adults.Journal of studies on alcohol and drugs · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Introduction: The COVID-19 pandemic may have affected young adult use of cannabis and other drugs. Prior research provides information about these effects, but additional estimates are needed using data collected in a consistent manner across years and in an established legalized cannabis context. The authors assessed changes in substance use among young adults in Washington State during the pandemic relative to prior trends. Methods: Data were from young adults aged 18-25 years in 6 annual waves of the statewide Washington State Young Adult Health Survey (N=12,516). In analyses conducted in 2023 and 2024, the authors estimated trends in substance use from 2016 to 2019 and deflections from those trends in 2020 and 2021. Results: Past-month cannabis use increased across years (annual percentage point change in 2016-2019 =1.6; 95% CI=0.6, 2.6), with little deflection from the prepandemic trend in 2020 or 2021. Prevalence of past-month alcohol use, heavy episodic drinking, cigarette use, and nonprescribed pain reliever use decreased across years (annual percentage point change range= -1.2, -0.5), with a further downward deflection from the prepandemic trend for cigarette use in 2020 (percentage point change= -3.8; 95% CI= -6.2, -1.4). Prevalence of simultaneous alcohol and cannabis use was stable across the study period. E-cigarette use increased before pandemic (annual percentage point change=1.8; 95% CI=1.2, 2.5) but fell below this trend in 2020 (percentage point change= -2.9; 95% CI= -4.8, -1.1) and 2021 (percentage point change= -3.2; 95% CI= -5.3, -1.0). For those aged <21 years compared with those aged ≥21 years, there was a downward deflection in cannabis use in 2020 (percentage point change=7.5; 95% CI=0.1, 14.9) and greater decrease in nonprescribed pain reliever use before pandemic (annual percentage point change=1.3; 95% CI=0.3, 2.3) followed by a relative increase in 2020 (percentage point change= -5.5; 95% CI= -11.6, 0.5). Sex differences in changes were not statistically significant, but females increased in most types of substance use relative to males across the study period. Conclusions: Prepandemic trends in cannabis and alcohol use continued through 2021, pointing to continuity in demand and supply, although the pandemic may have dampened cannabis use in 2020 for young adults aged <21 years. Decreases in nicotine use after 2019 may be partly due to restrictions on sales enacted in 2020 and warnings of COVID-19 risk linked to smoking and vaping. The findings point to the need for continued substance use prevention and treatment services during disruptive public health crises.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.